Veracyte's total assets for Q3 2025 were $1.37B, an increase of 1.76% from the previous quarter. VCYT total liabilities were $110.12M for the fiscal quarter, a -10.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.